Tetsuro Maeda, MD @tm_nyc_ profile

Tetsuro Maeda, MD

@tm_nyc_

Followers

128

Following

22

Statuses

158

🇯🇵(Kobe, Kyoto, Okinawa)→🇺🇸(NYC→Rochester, NY→Birmingham, AL) Assistant Prof. @UAB PACCM. Interested in relationship of COPD and cardiovascular disease.

Birmingham, AL

Joined July 2012

Don't wanna be here? Send us removal request.

Tetsuro Maeda, MD

@tm_nyc_

2 months

RT @NEJM: Depemokimab in Asthma with Eosinophilic Phenotype (SWIFT-1 and SWIFT-2 trials) Subscribe to NEJM for th…

0

4

0

Tetsuro Maeda, MD

@tm_nyc_

2 months

RT @ATS_Assemblies: Today! Join our @ATS_AII Research Abstract Winner Presentations (Part 2) Webinar at 1pm Eastern. AII Assembly abstract…

0

2

0

Tetsuro Maeda, MD

@tm_nyc_

3 months

RT @donsin4: In celebration of World #COPD Day, @ERSpublications has just published a novel way of measuring biological age of patients wit…

0

19

0

Tetsuro Maeda, MD

@tm_nyc_

3 months

RT @JAMANetworkOpen: RCT: Air purifiers with high-efficiency particulate air-14 filters placed in residents’ rooms do not reduce the incide…

0

6

0

Tetsuro Maeda, MD

@tm_nyc_

3 months

RT @Ko__Harada: 【米国の臨床現場で使われるアプリ】米国の臨床現場は日本よりデジタル化がはるか先をいっています。スマホがなければ仕事にならないほどアプリも充実しています。今日は、日本ではあまり普及していない、米国の医療現場で使われるアプリをいくつか紹介します。…

0

106

0

Tetsuro Maeda, MD

@tm_nyc_

3 months

RT @NaruhisaOda: @YujiY0402 米国では肺炎球菌ワクチン(PCV15, PCV20 or PCV21)の対象年齢の見直しがCDCから発表されて、これまで65歳以上だったのが50歳以上に変更されました PneumoRecs VaxAdvisorというアプ…

0

3

0

Tetsuro Maeda, MD

@tm_nyc_

3 months

RT @ATSBlueEditor: Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial In this trial of…

0

5

0

Tetsuro Maeda, MD

@tm_nyc_

4 months

RT @atscommunity: Approximately one month left to submit your Scientific Abstracts & Case Reports Abstracts for #ATS2025:

0

2

0

Tetsuro Maeda, MD

@tm_nyc_

4 months

RT @ERSpublications: ERJ Open Research: People with bronchiectasis have an increased risk for cardiovascular events, including coronary hea…

0

15

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

Pulmonary and CV meds and lung function trajectory in the Rotterdam cohort. ICS, LABA and maybe statin appear beneficial, and new use of beta-1 blocker was related to rapid lung function decline (but, driven by subjects without lung disease).

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

Ivacaftor for COPD

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

RT @Tanuk_Ichi: これ国際学会などで海外の医者に、日本のHPVワクチンの惨状の話をしてもマジで理解されない 👨‍⚕️"マスコミがこぞってanti-vaxxer(反ワクチン)の意見を垂れ流すなんてあり得るの？日本のマスコミには医療分野でのチェック体制がないの？"…

0

6K

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

RT @ProfHurst: This is a really important, and reassuring study, comparing 15 vs 24h/day long-term oxygen therapy in people with hypoxaemia…

0

13

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

RT @JAMA_current: High-intensity NPPV reduced the need for intubation in patients with acute COPD exacerbations with hypercapnia, but intub…

0

26

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

RT @NIH: News: Experimental blood test predicts risk for developing COPD, other severe respiratory diseases

0

20

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

RT @JAMANetwork: Reduced Cost Sharing and Medication Management Services for COPD: A Randomized Clinical Trial, from @JAMAInternalMed, free…

0

1

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) Editori…

0

69

0

Tetsuro Maeda, MD

@tm_nyc_

5 months

0

1

Tetsuro Maeda, MD

@tm_nyc_

5 months

0

2

Tetsuro Maeda, MD

@tm_nyc_

6 months

RT @YukiKotani5: Potassium supplementation thresholds for AF prevention after cardiac surgery: TIGHT-K trial❤️‍🔥 N = 1667 K < 3.6🆚K < 4.5…

0

8

0